Clinical trials sponsored by Cullinan Therapeutics Inc.
3
Recruiting trials
8
Conditions studied
Phase breakdown
Phase 1 3
Conditions studied
| Condition | Trials |
|---|---|
| Rheumatoid arthritis | 2 |
| Lupus | 1 |
| Rheumatoid Arthritis (RA | 1 |
| SLE | 1 |
| SLE (Systemic Lupus) | 1 |
| Sjogren Disease | 1 |
| Sjogren's Syndrome | 1 |
| Sjögren | 1 |
Recruiting trials led by Cullinan Therapeutics Inc.
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Common questions
How many trials is Cullinan Therapeutics Inc. recruiting for?
Cullinan Therapeutics Inc. is the lead sponsor of 3 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.